Nonsegmental Vitiligo

Paramedical tattoos can be used for vitiligo by color matching tattoo ink with patients’ skin tones in vitiligo-affected areas, according to a presenter at the American Society for Dermatologic Surgery Annual Meeting.

The first subject has been dosed in a phase 2b trial evaluating VYN201 for the treatment of active or stable nonsegmental vitiligo.

Ruxolitinib cream 1.5% was safe and well tolerated up for the short- and long-term treatment of atopic dermatitis in adolescents, according to an analysis of two phase 3 studies.

Safety data for ruxolitinib cream, a Janus kinase inhibitor, in the first year after its approval has shown that the drug is generally well tolerated for the treatment of atopic dermatitis or vitiligo, according to a postmarketing review.

SAN DIEGO — Patients with nonsegmental vitiligo continually improved with upadacitinib treatment up to 1 year, according to a speaker at the American Academy of Dermatology Annual Meeting.

SAN DIEGO — In patients with active nonsegmental vitiligo, ritlecitinib monotherapy or paired with twice weekly narrowband ultraviolet B phototherapy improved facial and total body repigmentation, according to a speaker here.